Cardiac sarcoidosis

American Heart Journal

Volumn 157, Issue 1, 2009, Pages 9-21

  Kim, Jessica S ^a   Judson, Marc A ^b   Donnino, Robert ^a   Gold, Michael ^b   Cooper Jr , Leslie T ^c   Prystowsky, Eric N ^d   Prystowsky, Stephen ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MAYO CLINIC   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; IMMUNOSUPPRESSIVE AGENT; INDIUM 111; INFLIXIMAB; IODINE 123; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE; TECHNETIUM 99M; THALIDOMIDE; THALLIUM 201;

ANEURYSM SURGERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DEFIBRILLATOR; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG ACCUMULATION; DRUG UPTAKE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE BIOPSY; HEART SARCOIDOSIS; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOIDOSIS; SCREENING; SUDDEN DEATH; SYMPTOM; SYNCOPE; THERAPY EFFECT;

ADRENAL CORTEX HORMONES; CARDIOMYOPATHIES; HUMANS; PROGNOSIS; SARCOIDOSIS;

EID: 57149098769     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.09.009     Document Type: Review

References (128)

1. Roberts W.C., McAllister H.A., and Ferrans V.J. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. Am J Med 63 (1977) 86-108
2. Hillerdal O., Niou E., and Osterman K. Sarcoidosis. Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 130 (1984) 29-32
3. Rybicki B.A., Major M., Popovich Jr. J., et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145 (1997) 234-241
4. Bresnitz E.A., and Strom B.L. Epidemiology of sarcoidosis. Epidemiol Rev 5 (1983) 124-156
5. Baughman R.P., Lower E.E., and du Bois R.M. Sarcoidosis. Lancet 361 (2003) 1111-1118
6. Smith G., Brownell I., Sanchez M., et al. Advances in the genetics of sarcoid. Clin Genet 73 (2008) 1-12
7. Martinetti M., Luisetti M., and Cuccia M. HLA and sarcoidosis: new pathogenic insights. Sarcoidosis Vasc Diff Lung Dis 19 (2002) 83-95
8. Grutters J.C., Sato H., Pantelides P., et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am Rev Respir Crit Care Med 165 (2002) 1119-1124
9. Takada T., Suzuki E., Morohash K., et al. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. J Rheumatol 29 (2002) 1671-1673
10. Rossman M.D., Thompson B., Frederick M., et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73 (2003) 720-735
11. Valentonyte R., Hampe J., Huse K., et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37 (2005) 357-364
12. Rybicki B.A., Walewski J.L., Maliarik M.J., et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77 (2005) 491-499
13. Cooper L.T. Giant cell and granulomatous myocarditis. Heart Fail Clin 1 (2005) 431-437
14. Iwai K., Sekiguti M., Hosoda Y., et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11 (1994) 26-31
15. Perry A., and Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 119 (1995) 167-172
16. Silverman K.J., Hutchins G.M., and Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58 (1978) 1204-1211
17. Cooper L.T. Cardiac sarcoidosis. In: Cooper L.T. (Ed). Myocarditis: From Bench to Bedside (2002), Humana Press, Totowa (NJ) 421-436
18. Iwai K., Tachibana T., and Takemura T. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 43 (1993) 372-376
19. Desai M.Y., and Fallert M.A. Rapidly progressing congestive heart failure due to cardiac sarcoidosis involving papillary muscles: a case report and brief review of the literature. Cardiol Rev 11 (2003) 163-168
20. Cross B., Nicolarsen J., Bullock J., et al. Cardiac sarcoidosis presenting as mitral regurgitation. J Am Soc Echocardiogr 20 (2007) 9069.e6-9069.e13
21. Halushka M.K., Yuh D.D., and Russell S.D. Right ventricle-dominant cardiac sarcoidosis with sparing of the left ventricle. J Heart Lung Transplant 25 (2006) 479-482
22. Goyal S.B., and Aragam J.R. Cardiac sarcoidosis with primary involvement of the tricuspid valve. Cardiol Rev 14 (2006) e12-e13
23. Butany J., Bahl N.E., Morales K., et al. The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol 15 (2006) 222-227
24. Lam C.S.P., Tolep K.A., Metke M.P., et al. Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol (2008) [in press]
25. Abrishami B., O'Connel C., and Sharma O. Cardiac sarcoidosis with presentation of large left atrial mass. Curr Opin Pulm Med 10 (2004) 397-400
26. Chapelon-Abric C., de Zuttere D., Duhaut P., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83 (2004) 315-334
27. Okura Y., Dec G.W., Hare J.M., et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41 (2003) 322-328
28. Nelson J.E., Kirschner P.A., and Teirstein A.S. Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis 13 (1996) 178-182
29. Fleming HA, Bailey SM. Sarcoid heart disease. J R Coll Physicians London 1981;15:245-246, 249-523.
30. Matsui Y., Iwai K., Tachibana T., et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann New York Acad Sci 278 (1976) 455-469
31. Smedema J.P., Snoep G., van Kroonenburgh M.P., et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 128 (2005) 30-35
32. Yazaki Y., Isobe M., Hiroe M., et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88 (2001) 1006-1010
33. Fleming H.A. Sarcoid heart disease. Br Heart J 36 (1974) 54-68
34. Gasparovic H., Bueno R., Rybicki F.J., et al. Sarcoidosis of the aortic root. J Thorac Cardiovasc Surg 128 (2004) 761-762
35. Handa T., Nagai S., Miki S., et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 129 (2006) 1246-1252
36. Shigemitsu H., Nagai S., and Sharma O.P. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med 13 (2007) 434-438
37. Konno T., Shimizu M., Ino H., et al. A rare type of alternating bundle branch block in a patient with cardiac sarcoidosis-a case report. Angiology 56 (2005) 115-117
38. Ramachandran V., Stevens M.P., Amin M., et al. Bi-fascicular block on EKG as the initial presenting sign of cardiac sarcoidosis. Int J Cardiol 118 (2007) e1-e2
39. Ahmad K., Kim Y.H., Spitzer A.R., et al. Total nodal radiation in progressive sarcoidosis. Case report. Am J Clin Oncol 15 (1992) 311-313
40. Winters S.L., Cohen M., Greenberg S., et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18 (1991) 937-943
41. Aizer A., Stern E.H., Gomes J.A., et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 96 (2005) 276-282
42. Kinney E., Murthy R., Ascunce G., et al. Pericardial effusions in sarcoidosis. Chest 76 (1979) 476-478
43. Zelcer A.A., LeJemtel T.H., Jones J., et al. Pericardial tamponade in sarcoidosis. Can J Cardiol 3 (1987) 12-13
44. Garrett J., O'Neill H., and Blake S. Sarcoidosis of the heart. Am Heart J 107 (1984) 394
45. Hiraga H., Yuwai K., Hiroe M., et al. Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases from the Japanese Ministry of Health and Welfare (1993), Japanese Ministry of Health and Welfare, Tokyo 23-24
46. Judson M.A., Baughman R.P., Teirstein A.S., et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999) 75-86
47. Judson M.A. A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI). Med Hypotheses 68 (2007) 1080-1087
48. Ratner S.J., Fenoglio Jr. J.J., and Ursell P.C. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 90 (1986) 528-533
49. Weinberg M., Fell E.H., and Lynfield J. Diagnostic biopsy of the pericardium and myocardium. AMA Arch Surg 76 (1958) 825-829
50. Ardehali H., Howard D.L., Hariri A., et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 150 (2005) 459-463
51. Tadamura E., Yamamuro M., Kubo S., et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185 (2005) 110-115
52. Uemura A., Morimoto S., Hiramitsu S., et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 138 (1999) 299-302
53. Pandya C., Brunken R.C., Tchou P., et al. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J 29 (2007) 418-422
54. Cooper L.T., Baughman K.L., Feldman A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 50 (2007) 1914-1931
55. Sekiguchi M., Yazaki Y., Isobe M., et al. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 10 (1996) 495-510
56. Numao Y., Sekiguchi M., Hirosawa K., et al. Evaluation of cardiac involvement through electrocardiogram in patients with sarcoidosis. Kokyu To Junkan 29 (1981) 421-428
57. Judson M.A. Cardiac sarcoidosis: there is no instant replay. Chest 128 (2005) 3-6
58. Mehta D., Lubitz S.A., Frankel Z., et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133 (2008) 1426-1435
59. Kinney E.L., Jackson G.L., Reeves W.C., et al. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. Am J Med 68 (1980) 497-503
60. Lewin R.F., Mor R., Spitzer S., et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 110 (1985) 116-122
61. Burstow D.J., Tajik J., Baily K.R., et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 63 (1989) 478-482
62. Gibbons W.J., Levy R.D., Nava S., et al. Subclinical cardiac dysfunction in sarcoidosis. Chest 100 (1991) 44-50
63. Angomachelelis N., Hourzamanis A., Vamvalis C., et al. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis. Postgrad Med J 68 (1992) S52-S56
64. Fahy G.J., Warwick T., McCreery C.J., et al. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109 (1996) 62-66
65. Hyodo E., Hozumi T., Takemoto Y., et al. Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart 90 (2004) 1275-1280
66. Hourigan L.A., Burstow D.J., Pohlner P., et al. Transesophageal echocardiographic abnormalities in a case of cardiac sarcoidosis. J Am Soc Echocardiogr 14 (2001) 399-402
67. Yamano T., and Nakatani S. Cardiac sarcoidosis: what can we know from echocardiography?. J Echocardiogr 5 (2007) 1-10
68. Bulkley B.H., Rouleau J.B., Whitaker J.Q., et al. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 72 (1977) 27-32
69. Tellier P., Paycha F., Antony I., et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 85 (1988) 189-193
70. Le Guludec D., Menad F., Faraggi M., et al. Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest 106 (1994) 1675-1682
71. Tellier P., Valeyre A., Nitenberg A., et al. Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med 11 (1985) 201-204
72. Haywood L.J., Sharma O.P., Siegel M.E., et al. Detection of myocardial sarcoidosis by thallium 201 imaging. J Natl Med Assoc 74 (1982) 959-964
73. Fields G., Ossorio M., Roy T., et al. Thallium 201 scintigraphy in the diagnosis the management of myocardial sarcoidosis. South Med J 83 (1990) 339-342
74. Yamagishi H., Shirai N., Takagi M., et al. Identification of cardiac sarcoidosis with 13N-NH3/18F-FDG PET. J Nucl Med 44 (2003) 1030-1036
75. Kaminaga T., Takeshita T., Yamauchi T., et al. The role of iodine-123-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 94 (2004) 99-103
76. Okumura W., Iwasaki T., Toyama T., et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45 (2004) 1989-1998
77. Kinney E.L., and Caldwell J.W. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms?. Angiology 41 (1990) 573-576
78. Kinney E.L., Jackson G.L., Reeves W.C., et al. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients. Am J Med 68 (1980) 497-503
79. Okayama K., Kurata C., Tawarahara K., et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107 (1995) 330-334
80. Kiuchi S., Teraoka K., Koizumi K., et al. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation. Int J Cardiovasc Imaging 23 (2007) 237-241
81. Nakazawa A., Ikeda K., Ito Y., et al. Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest 126 (2004) 1372-1376
82. Brudin L.H., Valind S., Rhodes C.G., et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 21 (1994) 297-305
83. Lewis P., and Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35 (1994) 1647-1649
84. Yokoyama I., Momomura S., Ohtake T., et al. Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy. EurJ Nucl Med 25 (1998) 736-743
85. Ishimaru S., Tsujino I., Takei T., et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26 (2005) 1538-1543
86. Smedema J.P., Reenaers V., and Geukens R. Cardiac sarcoidosis in a 60-year-old woman. Heart 92 (2006) 688
87. Takeda N., Yokoyama I., Hiroi Y., et al. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 105 (2002) 1144-1145
88. Tadamura E., Yamamuro M., Kubo S., et al. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation 113 (2006) e771-e773
89. Ohira H., Tsujino I., Ishimaru S., et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35 (2008) 933-941
90. van den Heuvel A.F., van Veldhuisen D.J., van der Wall E.E., et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 35 (2000) 19-28
91. Lebtahi R., Crestani B., Belmatoug N., et al. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med 42 (2001) 21-26
92. Knapp W.H., Bentrup A., and Ohlmeier H. Indium-111-labelled antimyosin antibody imaging in a patient with cardiac sarcoidosis. Eur J Nucl Med 20 (1993) 80-82
93. Matsuki M., and Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 55 (2000) 323-325
94. Inoue S., Shimada T., and Murakami Y. Clinical significance of gadolinium-DTPA-enhanced MRI for detection of myocardial lesions in a patient with sarcoidosis. Clin Radiol 54 (1999) 70-72
95. Shimada T., Shimada K., Sakane T., et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 110 (2001) 520-527
96. Vignaux O., Dhote R., Dudoc D., Blanche P., et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 26 (2002) 762-767
97. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184 (2005) 249-254
98. Smedema J.P., Snoep G., Van Kroonenburgh M.P., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45 (2005) 1683-1690
99. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
100. Vignaux O., Dhôte R., Duboc D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. A 1-year follow-up study. Chest 122 (2002) 1895-1901
101. Doherty M.J., Kumar K., Nicholson A.A., et al. Cardiac sarcoidosis: the value of magnetic resonance imagine in diagnosis and assessment of response to treatment. Respir Med 92 (1998) 697-699
102. Smedema J., Truter R., de Klerk P., et al. Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography. Int J Cardiol 112 (2006) 261-263
103. Kanao S., Tadamura E., Yamamuro M., et al. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging. J Comput Assist Tomogr 29 (2005) 745-748
104. Doughan A., and Williams B. Cardiac sarcoidosis. Heart 92 (2006) 282-288
105. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
106. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
107. Epstein A.E., Dimarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 117 (2008) 2820-2840
108. Grutters J.C., and van den Bosch J.M. Corticosteroid treatment in sarcoidosis. Eur Respir J 28 (2006) 627-636
109. Chiu C.Z., Nakatani S., Zhang G., et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 95 (2005) 143-146
110. Bargout R., and Kelly R.F. Sarcoid heart disease: clinical course and treatment. Int J Cardiol 97 (2004) 173-182
111. Kato Y., Morimoto S., Uemura A., et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 133-137
112. McNamara D.M., Holubkov R., Starling R.C., et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103 (2001) 2254-2259
113. Stanton C., Mookadam F., Cha S., et al. Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol 128 (2008) 38-41
114. Baughman R.P., Drent M., Kavuru M., et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174 (2006) 795-802
115. Baughman R.P., Costabel U., and du Bois R.M. Treatment of sarcoidosis. Clin Chest Med 29 (2008) 533-548
116. Baughman R.P., Ohmichi M., and Lower E.E. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18 (2001) 133-137
117. Baltzan M., Mehta S., Kirkham T.H., et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 160 (1999) 192-197
118. Muller-Quernheim J., Kienast K., Held M., et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 14 (1999) 1117-1122
119. Demeter S.L. Myocardial sarcoidosis unresponsive to steroids: treatment with cyclophosphamide. Chest 94 (1988) 202-203
120. Baughman R.P., Judson M.A., Teirstein A.S., et al. Thalidomide for chronic sarcoidosis. Chest 122 (2002) 227-232
121. Uthman I., Touma Z., and Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol 26 (2007) 2001-2003
122. Oni A., Hershberger R., Norman D., et al. Recurrence of sarcoidosis in a cardiac allograft control with augmented corticosteroids. J Heart Lung Transplant 11 (1992) 367-369
123. Yager J., Hernandez A., Steenbergen C., et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant 24 (2005) 1988-1990
124. Zaidi A.R., Zaidi A., and Vaitkus P.T. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 26 (2007) 714-717
125. Burke W.M.J., Keogh A., Maloney P.J., et al. Transmission of sarcoidosis via cardiac transplantation. Lancet 336 (1990) 1579
126. Daimon M., Sasaki T., Woo E., et al. Successful surgical treatment for dilated cardiomyopathy with cardiac sarcoidosis. Ann Thorac Surg 84 (2007) e12-e13
127. Jain A., Starek P.J., and Delany D.L. Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis. Clin Cardiol 13 (1990) 738-740
128. Lull R.J., Dunn B.E., Gregoratos G., et al. Ventricular aneurysm due to cardiac sarcoidosis with surgical cure of refractory ventricular tachycardia. Am J Cardiol 30 (1972) 282-287